In the ERA of New Direct Acting Antiviral Agents HCV Sequencing Allows the Most Accurate Subtype and Genotype AssignmentM. Aragri, Giustino Parruti, Velia Chiara Di Maio et al.|Journal of Hepatology|2016Cited by 1
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapiesVelia Chiara Di Maio, Valeria Pace Palitti, Valeria Micheli et al.|Digestive and Liver Disease|2017Cited by 1
Natural HCV resistance is common in Italy and differently associated to genotypesM.C. Sorbo, Francesca Ceccherini‐Silberstein, Valeria Cento et al.|Digestive and Liver Disease|2017Cited by 1
Early viral dynamics in HCV-RNA decay and NS3-resistance development predict the risk of failure to first-generation protease inhibitorsValeria Cento, Francesca Ceccherini‐Silberstein, F.P. Antonucci et al.|Digestive and Liver Disease|2014Cited by 0
P1235 BASELINE/EARLY PRESENCE OF KNOWN AND NOVEL RESISTANCE MUTATIONS IS ASSOCIATED WITH VIRAL FAILURE IN DIFFICULT-TO-TREAT PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORSValeria Cento, Francesca Ceccherini‐Silberstein, Velia Chiara Di Maio et al.|Journal of Hepatology|2014Cited by 0